Neutrophils from Both Susceptible and Resistant Mice Efficiently Kill Opsonized \u3cem\u3eListeria monocytogenes\u3c/em\u3e by Pitts, Michelle G. et al.
University of Kentucky
UKnowledge
Microbiology, Immunology, and Molecular
Genetics Faculty Publications
Microbiology, Immunology, and Molecular
Genetics
4-2018
Neutrophils from Both Susceptible and Resistant
Mice Efficiently Kill Opsonized Listeria
monocytogenes
Michelle G. Pitts
University of Kentucky, michelle.pitts@uky.edu
Travis A. Combs
University of Kentucky, travis.combs2@uky.edu
Sarah E. F. D'Orazio
University of Kentucky, sarah.dorazio@uky.edu
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/microbio_facpub
Part of the Immunology and Infectious Disease Commons, Medical Immunology Commons,
Medical Microbiology Commons, Microbiology Commons, and the Molecular Genetics Commons
This Article is brought to you for free and open access by the Microbiology, Immunology, and Molecular Genetics at UKnowledge. It has been accepted
for inclusion in Microbiology, Immunology, and Molecular Genetics Faculty Publications by an authorized administrator of UKnowledge. For more
information, please contact UKnowledge@lsv.uky.edu.
Repository Citation
Pitts, Michelle G.; Combs, Travis A.; and D'Orazio, Sarah E. F., "Neutrophils from Both Susceptible and Resistant Mice Efficiently Kill
Opsonized Listeria monocytogenes" (2018). Microbiology, Immunology, and Molecular Genetics Faculty Publications. 107.
https://uknowledge.uky.edu/microbio_facpub/107
Neutrophils from Both Susceptible and Resistant Mice Efficiently Kill Opsonized Listeria monocytogenes
Notes/Citation Information
Published in Infection and Immunity, v. 86, issue 4, e00085-18, p. 1-13.
Copyright © 2018 American Society for Microbiology. All Rights Reserved.
The copyright holder has granted the permission for posting the article here.
Digital Object Identifier (DOI)
https://doi.org/10.1128/IAI.00085-18
This article is available at UKnowledge: https://uknowledge.uky.edu/microbio_facpub/107
Neutrophils from Both Susceptible and Resistant Mice
Efficiently Kill Opsonized Listeria monocytogenes
Michelle G. Pitts,a Travis A. Combs,a Sarah E. F. D’Orazioa
aDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, Lexington,
Kentucky, USA
ABSTRACT Inbred mouse strains differ in their susceptibility to infection with the
facultative intracellular bacterium Listeria monocytogenes, largely due to delayed or
deficient innate immune responses. Previous antibody depletion studies suggested
that neutrophils (polymorphonuclear leukocytes [PMN]) were particularly important
for clearance in the liver, but the ability of PMN from susceptible and resistant mice
to directly kill L. monocytogenes has not been examined. In this study, we showed
that PMN infiltrated the livers of BALB/c/By/J (BALB/c) and C57BL/6 (B6) mice in sim-
ilar numbers and that both cell types readily migrated toward leukotriene B4 in an
in vitro chemotaxis assay. However, CFU burdens in the liver were significantly
higher in BALB/c mice than in other strains, suggesting that PMN in the BALB/c liver
might not be able to clear L. monocytogenes as efficiently as B6 PMN. Unprimed
PMN harvested from either BALB/c or B6 bone marrow killed L. monocytogenes di-
rectly ex vivo, and pretreatment with autologous serum significantly enhanced killing
efficiency for both. L. monocytogenes were internalized within 10 min and rapidly
triggered intracellular production of reactive oxygen species in a dose-dependent man-
ner. However, PMN from gp91phox-deficient mice also readily killed L. monocyto-
genes, which suggested that nonoxidative killing mechanisms may be sufficient for
bacterial clearance. Together, these results indicate that there is not an intrinsic de-
fect in the ability of PMN from susceptible BALB/c mice to kill L. monocytogenes and
further suggest that if PMN function is impaired in BALB/c mice, it is likely due to lo-
cally produced modulating factors present in the liver during infection.
KEYWORDS BALB/cBy/J mice, C57BL/6 mice, innate immunity, reactive oxygen
species, liver
Listeria monocytogenes is a facultative intracellular bacterium that causes foodbornedisease in humans. In mouse models of listeriosis, orally transmitted L. monocyto-
genes establishes infection in the gut and then spreads systemically to the spleen, liver,
and gallbladder (1, 2). Susceptibility to listeriosis varies among inbred mouse strains; for
example, compared to what is seen in C57BL/6 (B6) or C57BL/10 mice, bacterial burdens
rise to significantly higher levels and clearance is delayed in BALB/c mice (2–4). This
difference has been attributed primarily to facets of innate immunity, including differ-
ential expression of STAT4 and reduced or delayed secretion of tumor necrosis factor
alpha (TNF-), interleukin-12 (IL-12), and gamma interferon (IFN-) (5–8).
One mechanism for innate clearance of L. monocytogenes is direct killing by neu-
trophils (polymorphonuclear leukocytes [PMN]). Early work to deplete PMN from mice
relied on an antibody (clone RB6-8C5) that was subsequently shown to bind both PMN
and monocytes (9–13). More recent depletion strategies designed to avoid this issue
yielded conflicting results about the importance of PMN for clearance from the liver (14,
15). PMN in the liver were found either to kill bacteria released from apoptotic
hepatocytes or perhaps to directly lyse infected hepatocytes, releasing the bacteria
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from a protective niche (16–18). Despite PMN recruitment to the liver, CFU burdens in
BALB/c mice increased steadily for approximately 5 days; in contrast, exponential
growth of L. monocytogenes was restricted in B6 livers and the number of CFU began
to fall after approximately 3 days (2, 3). This suggests that BALB/c PMN might be less
efficient at killing L. monocytogenes than B6 PMN.
PMN make up the majority of immune cells in human blood but account for only
about 15% of circulating immune cells in the mouse (19, 20). Since human blood is
readily available in larger quantities than murine blood, human PMN are most com-
monly used for in vitro assays that study interactions of PMN with bacteria. Murine PMN
lack defensins and have a low affinity for the prototypical formylated peptide formyl-
methionyl-leucyl phenylalanine (fMLF), but they do possess a strong affinity for formy-
lated peptides derived from L. monocytogenes and Staphylococcus aureus (21–23).
Differences in relative speed and migration distance have also been noted when
murine and human PMN were compared in chemotaxis assays (24). The difficulty in
obtaining large numbers of PMN from mice and the potential for functional differences
with human cells have resulted in a lack of studies using murine PMN. However, PMN
isolated from human peripheral blood cannot be used to evaluate how PMN contribute
to susceptibility or resistance in mouse models of infection.
It has been estimated that mature PMN remain in the bone marrow of mice for up
to 2 days before being released into circulation (25). Boxio et al. first showed that
mouse bone marrow is an abundant source of morphologically mature PMN and that
these cells release both primary and secondary granules upon stimulation (26). Swa-
mydas and Lionakis further refined the enrichment protocol and showed that PMN
harvested from bone marrow could be used for adoptive transfer (27). In this study, we
used PMN enriched from the bone marrow of naive or infected BALB/c and B6 mice
and compared the abilities of the cells to kill L. monocytogenes directly ex vivo. We
demonstrate that murine neutrophils efficiently kill serum-opsonized L. monocytogenes
using both oxidative and nonoxidative mechanisms. We concluded that there were no
intrinsic differences in the capacity of PMN from susceptible BALB/c and resistant B6
mice to directly kill L. monocytogenes.
RESULTS
Hepatic PMN infiltration after foodborne infection is similar in BALB/c and B6
mice. Using the foodborne model of listeriosis in mice, L. monocytogenes colonizes the
gut tissue for 24 to 48 h and then spreads systemically to the spleen and liver (2, 28).
Differences in host susceptibility to infection can readily be observed in the liver, where
the number of CFU in susceptible BALB/c mice is significantly greater than in the more
resistant B6 mice (Fig. 1A) (2). Neutrophil-rich hepatic abscesses containing L. mono-
cytogenes were observed in both BALB/c and B6 mice 24 h after intravenous infection
(29). To verify that PMN were recruited to the liver parenchyma after foodborne
infection, livers were harvested after portal vein perfusion to remove blood, and Ly6Ghi
FIG 1 Neutrophil recruitment to the liver following foodborne infection is similar in B6 and BALB/c mice.
(A) Mice were fed 3  108 CFU of L. monocytogenes SD2000. At 3 dpi, livers were perfused and total CFU
was determined. The total number of Ly6Ghi Ly6C PMN found in the nonparenchymal fraction after
tissue digestion in uninfected (NI) or infected (3 d) mice was also determined. Pooled results from three
independent experiments are shown. (B) Migration of gradient-enriched PMN toward 100 nM leukotriene
B4 was monitored using an under-agarose assay. Representative results from one of three independent
experiments are shown (n  4 technical replicates per group).
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cells were identified by flow cytometry. At 3 days postinfection (dpi), there was a 5- to
10-fold increase in the number of PMN in the liver, with no significant difference
observed between BALB/c and B6 mice (Fig. 1A). Thus, a lack of PMN infiltration did not
explain the greater CFU burden in the BALB/c liver.
After reaching a tissue such as the liver, PMN must further sense and then migrate
toward specific chemoattractants, a process that was recently shown to create a
“swarm” at infectious foci (30). To test whether BALB/c cells had a chemotaxis defect,
we analyzed the ability of gradient-enriched PMN to migrate toward specific signals
using an under-agarose assay. We first tested L. monocytogenes-derived formylated
peptides, which were previously shown by Liu et al. to induce chemotaxis from mouse
PMN in a Boyden chamber assay (31). A combination of two formylated peptides (1 M
fMIVTLF plus 1 M fMIGWII; Bio-Synthesis, Inc.) did not induce migration in the
under-agar assay, despite triggering a burst of intracellular ROS when applied to either
BALB/c or B6 PMN (data not shown). However, leukotriene B4, a lipid-derived chemot-
actic signal produced by PMN (32), did induce migration of gradient-enriched murine
PMN. The maximum distance traveled in 3 h was approximately 900 m for both
BALB/c and B6 PMN (Fig. 1B). Together, these data indicated that recruitment of
circulating PMN and chemotaxis toward PMN-derived stimuli was similar in susceptible
BALB/c mice and resistant B6 mice.
Unprimed bone marrow neutrophils rapidly kill L. monocytogenes in the pres-
ence of autologous serum. Although there was no difference in PMN infiltration,
increased bacterial growth in BALB/c mice might also be due to an intrinsic defect in
the ability of BALB/c PMN to kill L. monocytogenes. To test this, we developed an in vitro
killing assay using PMN isolated from the bone marrow of uninfected mice. PMN were
enriched using gradient centrifugation, a method that typically yielded a 65 to 80%
pure population of Ly6Ghi neutrophils (Fig. 2A). The remaining cells were Ly6Chi
monocytes (1 to 5%), CD19 B cells (10 to 20%), and a small number of CD11b CD64
cells (data not shown). The enriched PMN were transferred to a 96-well flat-bottom
plate and incubated with L. monocytogenes at a low multiplicity of infection (MOI) for
90 min. As shown in Fig. 2B, there was only a 20% decrease in detectable CFU within
this time frame using PMN from either mouse strain.
FIG 2 Murine neutrophils kill L. monocytogenes efficiently in the presence of serum. Gradient-enriched
PMN were used to perform in vitro killing assays. (A) A representative dot plot shows the composition of
a typical gradient-enriched bone marrow prep; live- and single-cell gates were applied. (B) PMN (n  3
technical replicates) were incubated with L. monocytogenes at an MOI of 0.05 for 90 min. Pooled results
from 2 independent experiments are shown. (C) L. monocytogenes bacteria were pretreated as indicated
and added to PMN (MOI  0.1) for 60 min. Representative results from one of three independent
experiments are shown. (D) Serum-opsonized L. monocytogenes (MOI  2) was added to BALB/c PMN.
The absolute number of CFU remaining in the wells at either 1 h or 4 h for a representative experiment
is shown in the two graphs on the left. Dashed lines indicate the number of CFU at t  0. The mean
percentage killed at each time point ( SD) for three independent experiments is shown on the right.
ns, not significant.
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Bortolussi et al. previously showed that L. monocytogenes uptake by human PMN
was greatly enhanced when serum was present (33). To find out if killing efficiency
could be improved by exposure to serum proteins, we pretreated late-stationary-phase
bacteria with 10% autologous mouse serum for 30 min prior to the addition of PMN. As
shown in Fig. 2C, serum pretreatment significantly increased the killing rate within 1 h
for both BALB/c and B6 PMN. In contrast, pretreatment with heat-inactivated serum did
not enhance killing of L. monocytogenes. Thus, a heat-labile component found in naive
serum, most likely complement, contributed significantly to the ability of PMN to kill L.
monocytogenes in vitro. Accordingly, serum pretreatment was used for all subsequent
killing assays.
In the killing assays described above, the percentage of L. monocytogenes cells killed
was calculated by comparing the number of CFU recovered in the presence of PMN to
the number of CFU found in assay wells that contained only bacteria. Incubation of L.
monocytogenes in tissue culture medium for 1 h resulted in an approximate doubling
of the bacteria (Fig. 2D), a pattern that was consistently observed in all assays. The
number of CFU recovered after the addition of gradient-enriched PMN was significantly
less than the initial inoculum (Fig. 2D, dashed lines), demonstrating that the PMN were
actively killing bacteria within 1 h rather than simply inhibiting growth. However, given
that the PMN outnumbered the bacteria in these assays up to 10-fold, it was surprising
that so many viable L. monocytogenes cells remained in each well. To find out if a longer
incubation time would allow the PMN to completely clear the inoculum, the killing
assay was extended to 4 h. L. monocytogenes incubated in tissue culture medium alone
increased more than 30-fold during this time frame (Fig. 2D). When PMN were added,
the number of L. monocytogenes bacteria was 5-fold higher than the initial inoculum,
but this number represented an approximate 80% killing rate compared to bacterial
growth without PMN. Thus, prolonged incubation time did not increase the efficiency
of killing, and extending the incubation period just allowed any bacteria that evaded
contact with PMN to replicate exponentially.
Sorted bone marrow PMN maintain viability and killing capacity after in vitro
culture. Although gradient centrifugation provided a substantially enriched PMN
population to study, it was unknown whether any of the killing observed could be
ascribed to the contaminating cells, which typically made up 20 to 35% of the enriched
population. To investigate this, three populations of cells were sorted from BALB/c and
B6 bone marrow: Ly6Ghi Ly6C PMN, Ly6Chi Ly6G monocytes, and the residual Ly6G
Ly6C cells (Fig. 3A). Each population was plated separately and incubated with L.
monocytogenes for 1 h. As shown in Fig. 3B, sorted PMN from both BALB/c and B6 mice
FIG 3 Sorted murine neutrophils efficiently kill L. monocytogenes. (A) Representative plots depict the
three populations of cells sorted from marrow of BALB/c (top row) and B6 (bottom row) mice. (B) Sorted
cells were plated in medium for 1 h, and then serum-opsonized L. monocytogenes was added (MOI 0.1);
killing efficiency was assessed after 50 min. (C) Sorted cells were cultured overnight at 37°C in 7% CO2.
The following day, a killing assay was performed as described above. Results from one of two indepen-
dent experiments with 3 technical replicates per group are shown.
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killed nearly 80% of the bacteria. Neither monocytes nor the residual population of
primarily B cells were capable of killing the bacteria directly ex vivo. These results
indicated that murine bone marrow PMN could be sorted without deleterious effects
and suggested that the killing observed with gradient-enriched cells was attributable
only to the PMN.
To assess the functional ex vivo life span of murine bone marrow PMN, sorted cells
were cultured overnight and inoculated with L. monocytogenes the following day. As
shown in Fig. 3C, PMN remained capable of killing 60 to 70% of the inoculum after 24
h of in vitro culture. However, in contrast to what was observed directly ex vivo, Ly6Chi
monocytes also killed approximately 60% of bacteria. Surprisingly, even the other cells,
which were comprised mainly of CD19 B cells, killed 30 to 40% of L. monocytogenes
cells (Fig. 3C). Therefore, murine PMN are viable and retain efficient killing ability for at
least 24 h after isolation from the bone marrow. However, these data indicate that only
highly purified sorted PMN should be used for experiments involving cells maintained
in culture for more than a few hours.
Bone marrow PMN rapidly internalize and kill L. monocytogenes intracellularly.
Human PMN are known to phagocytose particulate matter within seconds, followed by
rapid closure of the phagosome, which then fuses with granules containing an array of
antibacterial compounds (34). Extracellular killing mechanisms such as neutrophil
extracellular traps have also been described (35). To assess the importance of bacterial
internalization for in vitro killing of L. monocytogenes, sorted PMN were pretreated with
cytochalasin D, an inhibitor of actin polymerization. L. monocytogenes bacteria consti-
tutively expressing green fluorescent protein (GFP) were added, and differential “in/
out” staining was performed 10 min later. Nonpermeabilized cells were stained with
Texas Red-conjugated polyclonal anti-L. monocytogenes antibodies such that cell-
associated extracellular bacteria appeared yellow (Fig. 4A). Bacteria that were internal-
ized by the PMN, and thus not accessible to the antibodies, appeared green. As shown
in Fig. 4A, approximately 90% of the cell-associated L. monocytogenes cells were
intracellular 10 min after incubation with either BALB/c or B6 PMN. Pretreatment with
cytochalasin D decreased the percentage of intracellular bacteria but did not com-
pletely block uptake. Killing assays performed simultaneously also showed a significant
reduction in the percentage of bacteria killed when cytochalasin D was used (Fig. 4B).
These results indicated that phagocytosis contributes to the ability of mouse bone
marrow PMN to efficiently kill serum-opsonized L. monocytogenes.
FIG 4 Murine neutrophils rapidly internalize L. monocytogenes in vitro. (A) Serum-opsonized L. monocytogenes bacteria constitutively
expressing GFP (L. monocytogenes SD2710) were added to sorted PMN (MOI  1) that were pretreated for 45 min with either 20 M
cytochalasin D (cyto D) or DMSO (vehicle). Cell-associated L. monocytogenes bacteria were visualized by differential in/out staining 10 min
postinfection. Representative images show intracellular (green) and extracellular (yellow) bacteria (bar, 2 M), and the mean percentage
of internalized bacteria in three independent experiments is shown. (B) A representative killing assay was performed at 50 min for cells
treated as described for panel A; bars indicate means  standard deviations (SD). (C) Gentamicin protection assay performed with
serum-opsonized L. monocytogenes and gradient-enriched PMN (n  3 technical replicates) and incubated for 10 min before addition of
gentamicin. Gentamicin was added at t  10 min as indicated by the arrowheads. Data from two independent experiments (Exp 1, Exp
2) are shown.
Murine Neutrophils Are Listericidal Infection and Immunity
April 2018 Volume 86 Issue 4 e00085-18 iai.asm.org 5
To investigate the possibility that L. monocytogenes might be efficiently internalized
by murine PMN but not killed within the short time period of these assays, a gentamicin
protection assay was performed to quantify intracellular bacteria. L. monocytogenes was
added to gradient-purified PMN, and gentamicin was added 10 min later. As shown in
Fig. 4C, 10 g/ml gentamicin was sufficient to kill 100% of the 1  105 CFU added to
each well in the absence of PMN. At 25 min, 50 to 200 gentamicin-resistant CFU were
detected per well (0.05 to 0.2% of the initial inoculum). The number of intracellular L.
monocytogenes bacteria did not change at 35 or 45 min postinfection (Fig. 4C). These
data suggested that a small number of L. monocytogenes cells may be able to avoid
killing and survive intracellularly. However, the negligible number of gentamicin-
resistant bacteria were not likely to influence the percent killed calculations in the
in vitro killing assays.
L. monocytogenes induces a respiratory burst in unprimed murine PMN. One of
the ways PMN can kill bacteria is though targeted release of reactive oxygen species
(ROS). To measure the induction of ROS in PMN exposed to L. monocytogenes, dihy-
drorhodamine 123 (DHR) fluorescence was used. DHR diffuses across the cell mem-
brane and fluoresces when oxidized to rhodamine by either peroxynitrite, a product of
nitric oxide and superoxide, or hypochlorous acid (36). The short incubation period of
the assays described here was not likely to activate inducible nitric oxide synthase
(iNOS) (37, 38); therefore, in this system, DHR served primarily as a measure of the
amount of hypochlorous acid produced by the PMN.
Gradient-enriched PMN from BALB/c and B6 mice were incubated in medium for 1
h and then suspended in buffer prior to the addition of serum-opsonized L. monocy-
togenes. As shown in Fig. 5A, when the bacteria were added at a low MOI, less than 25%
of the PMN produced ROS within 30 min. When 10-fold-more bacteria were added, the
number of ROS-positive cells increased significantly for both BALB/c and B6 PMN. Thus,
unprimed PMN from both mouse strains rapidly responded to the presence of L.
monocytogenes by producing ROS in a dose-responsive manner. Although increasing
the MOI resulted in a more robust respiratory burst, the killing efficiency remained at
60 to 80% (Fig. 5B), as was observed previously for assays using lower MOIs (compare
Fig. 5B to Fig. 2C, 3B, and 4B). Together, these observations suggested that ROS might
not be required for efficient killing during the in vitro assay.
Murine PMN use both oxidative and nonoxidative mechanisms to kill L. mono-
cytogenes. To specifically assess the importance of ROS for killing of L. monocytogenes,
FIG 5 L. monocytogenes induces a dose-dependent ROS burst in murine neutrophils. Gradient-enriched
neutrophils suspended in HBSS were incubated with dihydrorhodamine 123 prior to the addition of L.
monocytogenes at MOIs of 4 (red) and 40 (blue); mock-infected cells are shown in gray. (A) Representative
histograms for cells harvested 30 min after addition of bacteria and total ROS Ly6Ghi Ly6C PMN are
shown. (B) Gradient-enriched PMN were used for an in vitro killing assay (MOI 10). Killing efficiency was
assessed after 50 min. Representative results from one of three experiments using 3 to 5 technical
replicates per treatment are shown. Bars indicate means  SD.
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PMN from gp91phox-deficient mice were compared to wild-type B6 PMN. The gp91phox-
deficient mice lack a functional allele for the large gp91 subunit of NADPH oxidase;
thus, the enzyme cannot assemble (39). As shown previously, there was a dose-
dependent response for wild-type B6 PMN, with an MOI of 10 inducing more ROS-
positive cells than even phorbol myristate acetate (PMA) treatment (Fig. 6A). PMN from
gp91phox-deficient mice produced no detectable ROS at low MOI or after treatment
with PMA, but 2 to 5% of the cells became rhodamine positive when L. monocytogenes
was added at an MOI of 10. A simultaneous killing assay done with these cells showed
that gp91phox/ PMN were as capable of killing L. monocytogenes as cells from the
wild-type NADPH oxidase-sufficient mice, regardless of the MOI used (Fig. 6A). Thus, in
genetically deficient mice that were unable to produce ROS from birth, nonoxidative
mechanisms were sufficient to kill L. monocytogenes.
As an alternate approach to block ROS activity in both BALB/c and B6 mice,
4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (4-hydroxy Tempo [Tempol]) was used to
scavenge superoxide produced in response to L. monocytogenes. Tempol is a pleiotro-
pic antioxidant with both superoxide dismutase- and catalase-like properties (40, 41).
Gradient-enriched PMN were pretreated with Tempol for 90 min prior to the addition
of L. monocytogenes, and DHR was added to the samples to report the generation of
ROS. As shown in Fig. 6B, approximately 20 to 30% of either BALB/c or B6 PMN
produced high levels of ROS within 30 min, and pretreatment with Tempol significantly
reduced the percentage of ROShi cells detected. Tempol treatment also resulted in a 10
to 15% reduction in killing by PMN from both mouse strains (Fig. 6B). These data
indicated that in mice genetically capable of producing ROS, scavenging oxidative
intermediates (causing less hypochlorous acid to be available) reduced killing efficiency
in PMN. However, these data were also consistent with the conclusion that oxidative
killing mechanisms are not required to eliminate L. monocytogenes.
Since oxidative mechanisms were not required to kill L. monocytogenes, we hypoth-
esized that inhibition of proteases such as elastase, cathepsin G, and proteinase 3
would result in at least partial loss of killing capacity. To test this, gradient-enriched
FIG 6 ROS is not required for efficient in vitro killing of L. monocytogenes. (A) Gradient-enriched PMN from gp91phox/ and
B6 mice were loaded with DHR prior to addition of either serum-opsonized L. monocytogenes or 20 nM PMA. ROS levels
were determined at 30 min, and a killing assay was performed at 50 min. Pooled data from two independent experiments
are shown; horizontal bars indicate means SD. (B) Gradient-enriched PMN were incubated with 50 M Tempol or vehicle
for 90 min prior to addition of L. monocytogenes, and the percentage of ROShi neutrophils and the killing efficiency for
these cells were determined. Data from one of three independent experiments are shown; bars indicate means  SD. (C)
Gradient-enriched BALB/c PMN were incubated with DFP for 30 min at the indicated concentrations prior to addition of
L. monocytogenes (MOI  10). ROS activity was determined 30 min later, and the percent killed was determined 50 min
after addition of bacteria (n  5). Representative results from one of two independent experiments are shown. Solid gray
histogram indicates uninfected cells. (D) Gradient-enriched PMN from gp91phox/ males were treated with DFP at the
indicated concentrations or vehicle (veh) for 30 min prior to addition of L. monocytogenes (MOI  10) for an in vitro killing
assay. Bars indicate means for 6 replicates from one of two independent experiments.
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PMN were incubated with diisopropylfluorophosphate (DFP), a nonspecific serine
protease inhibitor. DFP was previously reported to inhibit protease activity without
affecting production of ROS (42). Treatment with 5 mM DFP resulted in a significant
reduction in PMN killing ability (Fig. 6C). However, treatment with 5 mM DFP also
completely inhibited the ROS response in PMN exposed to L. monocytogenes. Lowering
the concentration to 0.2 mM DFP eliminated the effect on ROS activity, but this
concentration did not inhibit bacterial killing (Fig. 6C). Therefore, it was not possible to
determine whether the loss of killing efficiency was due to a loss of serine protease
activity or a reduction in ROS availability in wild-type mice. DFP treatment of PMN from
gp91phox-deficient mice, however, did result in a significant loss of killing, suggesting
that full protease activity is important for optimal killing in the absence of ROS (Fig. 6D).
PMN harvested from infected BALB/c and B6 mice kill L. monocytogenes with
similar efficiency. Since murine PMN largely stay sequestered in bone marrow until
receiving a chemotactic signal to egress into the circulation, the cells used in our in vitro
assays were likely to be less activated than cells that are primed to infiltrate infected
tissues. To assess the ability of activated cells to kill L. monocytogenes, we harvested
bone marrow from BALB/c and B6 mice 2 days after foodborne infection with L.
monocytogenes. At this time point, there are typically no CFU in the bone marrow;
however, there are cells producing IFN-, and monocytes still in the marrow have
undergone inflammatory changes (43). Likewise, PMN in the marrow of both BALB/c
and B6 mice had uniformly upregulated CD11b expression (Fig. 7A). CD11b is a
component of complement receptor 3, and it was previously shown that CD11b
increased on the surface of human PMN after activation (44–46). However, no signifi-
cant differences were observed for the ability of CD11bhi PMN to kill L. monocytogenes
in vitro compared to cells from uninfected mice (Fig. 7A). Thus, unprimed cells from the
marrow of uninfected mice behaved very similarly to primed cells from the marrow of
infected mice.
To assess the ability of activated cells that had already emigrated from the bone
marrow, we isolated PMN from infected livers. Collagenase-perfused livers were har-
vested from both BALB/c and B6 mice at 3.5 days after infection. PMN were gradient
enriched, and then kanamycin-resistant L. monocytogenes was added. As shown in Fig.
7B, these cells killed 30 to 40% of the added L. monocytogenes. Together, these results
suggest that there are no intrinsic differences in the ability of PMN from susceptible
BALB/c or resistant B6 mice to clear L. monocytogenes infection.
DISCUSSION
To begin to address the possibility that susceptibility to listeriosis was determined
by an intrinsic defect in PMN function in mice, we developed an in vitro killing assay
using PMN enriched from murine bone marrow. We found that murine PMN killed
opsonized L. monocytogenes efficiently even without being primed with agents such as
FIG 7 Neutrophils harvested from the bone marrow of infected BALB and B6 mice kill Listeria with similar efficiency.
(A) CD11b surface expression on sorted PMN from uninfected mice (NI) or mice fed 3  108 CFU L. monocytogenes
SD2000 (2 dpi) was determined. Representative flow cytometry histograms are shown. PMN were incubated with
strain SD2001 for 50 min, and the percentage of kanamycin-resistant bacteria killed was determined. Bars indicate
means  SD for 6 technical replicates from one of three independent experiments. (B) BALB/c and B6 female mice
were fed 1  109 CFU L. monocytogenes, and livers were harvested at 3.5 dpi following collagenase perfusion via
the portal vein. The enriched nonparenchymal fraction was plated and exposed to strain SD2001 at the indicated
MOI for 50 min, and the percentage of kanamycin-resistant bacteria killed was determined. Bars indicate means 
SD for 6 technical replicates from one of two independent experiments. ns, not significant.
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PMA or IFN-. Furthermore, murine PMN could be sorted and kept in culture for at least
24 h without affecting killing ability. We showed that there was no intrinsic difference
in the ability of BALB/c and B6 PMN to kill L. monocytogenes directly ex vivo. However,
it is possible that in vivo, there are substances produced in the BALB/c liver that inhibit
the function of PMN and thus contribute to the delayed clearance of L. monocytogenes.
In agreement with previous studies using human PMN (33, 47), we showed that
opsonization with naive serum significantly improved the ability of PMN to kill L.
monocytogenes. In vitro, complement may be fixed on the surface of L. monocytogenes
through the classical or alternative pathway (33, 48). In vivo, complement is rapidly
activated during inflammation and may also be activated by either proteases or
acute-phase proteins present during infection (49). The concentration of specific com-
plement components in the liver during L. monocytogenes infection is unknown, but
several studies have found increased expression of complement receptors on activated
PMN (44–46). In humans, specific antibodies may also be involved in enhancing uptake
and killing of L. monocytogenes. Using a rabbit model, Vahidy et al. demonstrated that
L. monocytogenes opsonized with immune serum was internalized to a significantly
greater extent than bacteria treated with nonimmune serum (50).
The ROS burst has long been thought of as a primary means by which PMN clear
microbes, through oxidative damage to bacterial DNA, peroxidation of membrane
lipids, and other mechanisms (37). ROS might also increase the K concentration in
vacuoles, raising the pH and releasing proteases from an anionic matrix to allow for
optimal protease activity (51). Assembly of the multicomponent NADPH oxidase is
triggered by the act of phagocytosis, resulting in targeted release of ROS (52, 53).
However, in this study, only a high MOI induced robust intracellular ROS production in
PMN and increased ROS activity did not result in more-efficient killing of L. monocyto-
genes. PMN from mice genetically unable to make ROS from birth had no defect in
killing L. monocytogenes; therefore, nonoxidative killing mechanisms are sufficient.
However, in animals capable of triggering an ROS burst, modulation of that response
led to reduced bacterial killing. The loss of killing capacity observed after Tempol
treatment was likely due to a disruption in the ratio of available oxygen intermediates.
Since Tempol has catalase-like activity and also acts as a superoxide dismutase mimetic
(40, 41), it presumably depletes the H2O2 that would normally be acted upon by
myeloperoxidase to form hypochlorous acid, the oxidizing agent for DHR 123 (36).
It is not surprising that L. monocytogenes can be resistant to killing by oxidative
mechanisms, as the bacteria are known to produce both catalase and superoxide
dismutase as protection against host-derived ROS (54). Previously, stationary-phase L.
monocytogenes bacteria were found to be more vulnerable to killing by human PMN
than logarithmic-phase bacteria, a result that was attributed to lower catalase produc-
tion (55). Furthermore, superoxide dismutase was found to be phosphorylated and thus
less active in stationary-phase L. monocytogenes (56). However, in our study, we found
no significant difference in the ability of murine PMN to kill either logarithmic-phase or
stationary-phase L. monocytogenes, and both cultures produced similar bubbling reac-
tions in the presence of hydrogen peroxide (M. G. Pitts, unpublished observation). The
L. monocytogenes cytolysin listeriolysin O (LLO) was also shown to inhibit the activation
of NADPH oxidase in macrophages (57); however, the toxin may be rapidly degraded
in PMN (58).
PMN granules contain a variety of proteins and peptides that provide nonoxidative
means of killing bacteria, including cathepsin G, elastase, proteinase 3, lactoferrin, and
lysozyme (59). Alford et al. showed that purified cathepsin G alone could kill either S.
aureus or L. monocytogenes (60). Since several of these compounds are serine proteases
(60, 61), we expected to find at least a partial loss of killing efficiency after pretreatment
with DFP, a serine protease inhibitor, but this occurred only in a gp91phox/
background. DFP was previously used to show that serine proteases were important for
human PMN to kill Streptococcus pneumoniae (62), but ROS activity was not monitored
in that study, so we cannot make a direct comparison to our results. DFP was also used
to inhibit proteolysis of CD43 on human PMN stimulated with opsonized zymosan; in
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that study, the DFP did not inhibit ROS generation (42). This suggests that the nature
of the phagocytosed particle may determine whether or not DFP impacts the ROS
burst.
Circulating PMN are readily obtained from human peripheral blood; however, the
cells are easily affected by ex vivo isolation and labeling techniques and are prone to
rapid cell death (25, 63–65). In contrast, mature PMN harvested from the bone marrow
have a longer half-life, can be maintained in culture for at least 24 h (26), and as we
showed here, are not affected by manipulations such as cell sorting. A key advantage
of using unprimed cells, rather than cells that have already egressed from the bone
marrow, is the ability to study how specific inflammatory signals alter the functional
properties of the PMN. An important challenge for future work will be to understand
how signals in infected tissues such as the liver may affect the function of PMN during
infection.
MATERIALS AND METHODS
Bacteria. Mouse-adapted (InlAm-expressing) L. monocytogenes EGDe derivatives SD2000, SD2001
(kanamycin resistant), and SD2710 (constitutive GFP) were used in this study (43, 66). A freshly streaked
colony was inoculated into brain heart infusion (BHI) broth (Difco) and grown with shaking at 37°C
overnight (16 h). For in vitro assays, L. monocytogenes cells were washed once with Ca2/Mg2-free
Hanks’ balanced salt solution (HBSS; Gibco) and then diluted in the same buffer. For serum pretreatment,
autologous mouse serum was added (final concentration, 10%) for 30 min. Pretreatment with serum
alone in the absence of PMN had no effect on L. monocytogenes growth (data not shown). Heat-
inactivated serum was incubated at 55°C for 30 min.
Mice. BALBcBy/J (BALB/c; stock number 001026), C57BL/6J (B6; stock number 000664), and B6.129S-
Cybbtm1Din/J (gp91phox/; stock number 002365) mice were purchased from The Jackson Laboratory (Bar
Harbor, ME) and housed in a specific-pathogen-free facility. Bone marrow was harvested from both male
and female animals 8 to 16 weeks old; no significant differences were noted in PMN recovery per gram
of weight between male and female mice. Blood was collected from the aorta immediately after
euthanasia and transferred to a serum separator tube (BD), followed by centrifugation for 2 min at 20,000 
g. Serum was stored at 4°C for use the same day or at 80°C for later use. All procedures were approved
by the Institutional Animal Care and Use Committee at the University of Kentucky.
Liver nonparenchymal cell preparation. Mice were fed bread contaminated with L. monocytogenes
SD2000 as described previously (67, 68); control mice were fed phosphate-buffered saline (PBS)-saturated
bread pieces. Livers were perfused via the hepatic portal vein with 11 ml of collagenase type IV solution
(250 U/ml in HBSS; Worthington), removing blood present in the tissue. The perfused tissue was cut into
small pieces, transferred to a 50-ml tube containing DNase (10 U/ml; Worthington) and collagenase type
IV (100 U/ml) in 10 ml of RP-5 medium (RPMI 1640 [Life Technologies number 21870], 5% fetal bovine
serum [FBS; Gemini], 2.5 mM L-glutamine, 10 mM HEPES, and 0.1 mM 2-mercaptoethanol [Sigma-
Aldrich]), and incubated for 35 min with shaking at 37°C. The digested tissue was gently pushed through
a mesh screen (number 80 mesh) to create a single-cell suspension. At this point, 1/10 of the volume was
removed for determination of CFU burdens. Nonparenchymal cells were enriched by allowing 2 min of
settling time followed by centrifugation for 1 min at 50  g at 4°C. Supernatant was centrifuged at
300  g at 4°C for 10 min, the pellet was suspended in 30 ml of RPMI 1640, and the prior two steps were
repeated. Finally, the pellet was suspended in 1.6 ml cold RPMI 1640 followed by addition of 2.4 ml cold
40% Histodenz (Sigma) in PBS. The suspension was layered under 2 ml of cold RPMI 1640 in 15-ml
polyethylene terephthalate (PET) tubes (Corning) that had been precoated with FBS. Samples were
centrifuged for 20 min at 4°C at 1,500 g with no brake. The interface was collected and passed through
a filter to remove clumps.
Bone marrow harvest. Marrow was flushed from femurs and tibias with medium containing 2 M
EDTA (Gibco) and 25 g/ml gentamicin (Gibco). Cells (two bones per tube) were passed through a sterile
mesh filter into a 15-ml PET tube and pelleted by centrifugation at 400  g. Erythrocytes were lysed by
exposure to 0.2% NaCl for 20 s followed by addition of an equal volume of 1.6% NaCl.
Density gradient enrichment of PMN. Following erythrocyte lysis, PMN were enriched as described
previously (27). The bottom layer of cells was recovered and suspended in RP-10 (same as RP-5 but with
10% FBS) or flow cytometry buffer (Ca2/Mg2-free HBSS, 25 mM HEPES, 5 mM EDTA, 1% FBS).
Flow cytometry. Cells were stained using fluorescently conjugated antibodies specific for the
following molecules: Ly6C (HK1.4) and Ly6G (1A-8), purchased from Biolegend; CD11b (M1/70), CD3
(500A2), B220 (RA3-6B2), CD64 (X54-5/7.1), and CD19 (1D3), purchased from eBioscience. Neutrophils
were defined as Ly6Ghi Ly6C/, monocytes as Ly6G Ly6Chi, and B cells as Ly6G Ly6C CD19. The sort
gating strategy incorporated live-cell and singlet gates prior to gating on individual markers; sort purities
for PMN ranged from 92 to 99%. Cells were sorted into flow cytometry buffer containing 50% FBS and
25 g/ml gentamicin and then washed twice with RP-10 medium. Fluorescence was measured using an
LSR II flow cytometer (BD Biosciences) or an iCyt Synergy sorter, and analysis was performed using FlowJo
v.10 (Tree Star).
In vitro killing assay. Neutrophils (105/well) were plated in 96-well flat-bottom tissue culture-treated
plates in 100 l in RP-10 and incubated at 37°C in 7% CO2 for 1 h to allow a period of recovery. L.
monocytogenes was added at the indicated MOI in a volume of 20 to 40 l to 3 to 6 wells per sample
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group. In each experiment, a group of wells contained bacteria only (no PMN) to assess growth/survival.
The plate was centrifuged at 300 g for 5 min and then incubated at 37°C in 7% CO2. At each time point,
the content of each well was transferred to individual microcentrifuge tubes and wells were vigorously
washed 3 times with PBS and examined microscopically to ensure that all cells were removed. Serial
dilutions of each well were prepared in PBS and plated on BHI agar (Difco). The percentage of L.
monocytogenes killed was calculated by dividing the number of CFU from wells with PMN by the mean
number of CFU from wells without PMN.
Gentamicin protection assay. Gradient-enriched PMN were plated and exposed to serum-
opsonized L. monocytogenes as described above. Gentamicin was added at a final concentration of 10
g/ml 10 min later. At indicated time points, the cells were washed once with RP-10, lysed by addition
of sterile water, and plated on BHI agar.
Chemotaxis assay. An under-agarose assay was used as described previously by Heit and Kubes (69),
with the exception of the following modifications. Ultrapure agarose (1%; Invitrogen) was dissolved in
Ca2/Mg2-free HBSS and diluted with phenol red-free RPMI 1640 containing a final concentration of
2.5% FBS. FBS-coated 60-mm petri dishes were filled with 4.5 ml of the agarose mixture. Three-millimeter
holes were cored 2 mm apart using a sterilized template made from a silicone sheet and a hollow punch
tool. Either 1 M formylated synthetic peptide (fMIVTLF plus fMIGWII; Bio-Synthesis, Inc.) or 100 nM
leukotriene B4 (Cayman Chemical) diluted in Ca2/Mg2-free HBSS was applied to the center well and
allowed to diffuse into the gel prior to addition of gradient-enriched PMN (2  105/well) to the outer
wells. Dishes were incubated at 37°C in 7% CO2 for 3 h. Images were acquired in differential interference
contrast (DIC) mode with a Nikon A1R confocal microscope, using a 10 air objective with a numerical
aperture of 0.45 and the transmitted light detector. Image seize was 4,096 by 4,096 pixels with a
resolution of 0.31 m/pixel. The distance traveled was determined using the manual measurement tool
in the NIS-Elements software program (Nikon).
Immunofluorescence microscopy. Sorted PMN were plated in RP-10 and rested for 1 h, and then
cytochalasin D (Sigma) (20 M in dimethyl sulfoxide [DMSO]) was added and cells were incubated for 45
min at 37°C in 7% CO2. L. monocytogenes SD2710 was added to the wells, and the plate was centrifuged
for 5 min at 300 g, followed by incubation for 5 min at 37°C in 7% CO2. Difco Listeria O Antiserum Poly
(BD Biosciences) and goat anti-rabbit IgG-Texas Red (Thermo Fisher) were used to perform differential
“in/out” staining as described previously (43). Cells were visualized using a Zeiss Axio Imager.Z1 with a
100/1.4 NA PlanApo oil immersion objective and analyzed with AxioVision software. Slides were
blinded and examined by two different investigators; average values are reported.
Reactive oxygen species. Gradient-enriched PMN were plated in RP-10, rested for 1 h, and then
centrifuged at 300  g and suspended in Ca2/Mg2-free HBSS. Dihydrorhodamine 123 (DHR; Cayman
Chemical number 85100) suspended in DMSO and diluted in HBSS was added to wells (final concen-
tration, 2.5 g/ml) 15 min prior to addition of either L. monocytogenes or 20 nM PMA diluted in HBSS
(Sigma catalog number P1585). Plates were centrifuged at 300  g for 5 min and then incubated at 37°C
in 7% CO2. To scavenge reactive oxygen intermediates, cells were incubated for 90 min with 50 mM
4-hydroxy Tempo dissolved in HBSS (Tempol, Sigma catalog number 176141). L. monocytogenes was
added at the indicated MOI, and the mixture was further incubated for 30 min. DHR was added during
the final 15 min of incubation.
Serine protease inhibition. Cells were treated with diisopropylfluorphosphate (DFP; Sigma catalog
number D0879), suspended in isopropanol, and diluted in HBSS for 30 min at 37°C in 7% CO2. DHR was
added to the wells prior to addition of L. monocytogenes. For flow cytometry analysis, cells were washed,
stained with fluorescently tagged anti-Ly6G antibody, and fixed in 10% formalin after incubation with
bacteria.
Statistical analysis. Statistical analysis was performed using Prism 6 for Macintosh. Unless otherwise
indicated, unpaired Student’s t tests were performed. P values of 0.05 were considered significant and
are indicated in the figures by asterisks: *, P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001.
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